| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.629 | 0.008 | 0.629 | 5 Hydroxytryptamine release inhibitor | 0.519 0.027 CHEMBL3527501 | ||
| 0.62 | 0.016 | 0.62 | Aldehyde oxidase inhibitor | |||
| 0.607 | 0.018 | 0.769 | Cholesterol antagonist | 0.769 0.005 CHEMBL3527501 | CHEMBL3527501 | |
| 0.574 | 0.011 | 0.574 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.554 | 0.016 | 0.568 | Histamine release inhibitor | 0.568 0.014 CHEMBL3527501 0.466 0.042 CHEMBL3527502 | CHEMBL3527501 | |
| 0.504 | 0.005 | 0.504 | Alpha-N-acetylglucosaminidase inhibitor | 0.461 0.006 CHEMBL3527501 | ||
| 0.442 | 0.004 | 0.442 | Porphobilinogen synthase inhibitor | |||
| 0.44 | 0.004 | 0.44 | Succinate dehydrogenase inhibitor | 0.159 0.096 CHEMBL3527501 | ||
| 0.439 | 0.003 | 0.439 | Ferrochelatase inhibitor | |||
| 0.434 | 0.003 | 0.434 | Dihydroorotate dehydrogenase inhibitor | |||
| 0.43 | 0.002 | 0.43 | Dihydroorotase inhibitor | |||
| 0.463 | 0.044 | 0.463 | Calcium channel L-type activator | |||
| 0.391 | 0.014 | 0.627 | Non-steroidal antiinflammatory agent | 0.627 0.004 CHEMBL3527501 0.229 0.052 CHEMBL3527502 | CHEMBL3527501 | |
| 0.366 | 0.006 | 0.366 | GABA C receptor agonist | |||
| 0.364 | 0.004 | 0.364 | Alcohol oxidase inhibitor | |||
| 0.381 | 0.032 | 0.381 | Calcium channel activator | |||
| 0.455 | 0.108 | 0.826 | Antiinflammatory | 0.826 0.012 CHEMBL3527501 | CHEMBL3527501 | |
| 0.332 | 0.003 | 0.411 | Biliverdin reductase inhibitor | 0.411 0.002 CHEMBL3526652 0.121 0.014 CHEMBL3527501 | CHEMBL3526652 | |
| 0.36 | 0.034 | 0.36 | Superoxide dismutase inhibitor | |||
| 0.329 | 0.008 | 0.329 | M17 leucyl aminopeptidase inhibitor | |||
| 0.328 | 0.008 | 0.329 | Hexokinase inhibitor | 0.151 0.078 CHEMBL3526652 0.329 0.008 CHEMBL3527501 | CHEMBL3527501 | |
| 0.343 | 0.025 | 0.399 | Anesthetic general | 0.399 0.016 CHEMBL3527501 | CHEMBL3527501 | |
| 0.315 | 0.004 | 0.315 | Keratolytic | 0.077 0.053 CHEMBL3527501 | ||
| 0.315 | 0.004 | 0.325 | Triose-phosphate isomerase inhibitor | 0.325 0.004 CHEMBL3527501 | CHEMBL3527501 | |
| 0.311 | 0.005 | 0.311 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.28 0.007 CHEMBL3527501 0.083 0.075 CHEMBL3527502 | ||
| 0.324 | 0.019 | 0.324 | Gastrin inhibitor | 0.227 0.109 CHEMBL3527501 0.207 0.138 CHEMBL3527502 | ||
| 0.32 | 0.018 | 0.521 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.521 0.004 CHEMBL3526652 0.216 0.06 CHEMBL3527501 | CHEMBL3526652 | |
| 0.305 | 0.004 | 0.305 | Electrolyte absorption antagonist | |||
| 0.313 | 0.018 | 0.395 | Interferon gamma antagonist | 0.395 0.011 CHEMBL3527501 | CHEMBL3527501 | |
| 0.299 | 0.01 | 0.409 | UDP-glucose 4-epimerase inhibitor | 0.343 0.008 CHEMBL3526652 0.409 0.005 CHEMBL3527501 | CHEMBL3527501 | |
| 0.401 | 0.114 | 0.827 | Alpha-glucosidase inhibitor | 0.827 0.015 CHEMBL3527501 | CHEMBL3527501 | |
| 0.307 | 0.022 | 0.307 | Mcl-1 antagonist | 0.126 0.118 CHEMBL3527501 | ||
| 0.29 | 0.006 | 0.29 | Mannose-6-phosphate isomerase inhibitor | 0.283 0.007 CHEMBL3527501 | ||
| 0.358 | 0.082 | 0.358 | GABA C receptor rho-3 antagonist | |||
| 0.311 | 0.039 | 0.311 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.281 | 0.015 | 0.443 | Insulin secretagoues | 0.119 0.113 CHEMBL3526652 0.443 0.005 CHEMBL3527501 | CHEMBL3527501 | |
| 0.314 | 0.05 | 0.314 | Insulysin inhibitor | 0.313 0.051 CHEMBL3527502 | ||
| 0.295 | 0.037 | 0.295 | MAP kinase kinase 2 inhibitor | |||
| 0.373 | 0.128 | 0.373 | DNA directed DNA polymerase inhibitor | 0.242 0.197 CHEMBL3527501 | ||
| 0.267 | 0.028 | 0.267 | Diuretic | 0.215 0.039 CHEMBL3527501 | ||
| 0.277 | 0.042 | 0.498 | Peroxidase inhibitor | 0.498 0.01 CHEMBL3527502 | CHEMBL3527502 | |
| 0.281 | 0.058 | 0.37 | Interleukin agonist | 0.37 0.024 CHEMBL3527501 | CHEMBL3527501 | |
| 0.294 | 0.074 | 0.294 | Lipoxygenase inhibitor | |||
| 0.229 | 0.012 | 0.763 | Adenylate kinase inhibitor | 0.763 0 CHEMBL3526652 0.132 0.035 CHEMBL3527501 0.102 0.065 CHEMBL3527502 | CHEMBL3526652 | |
| 0.303 | 0.085 | 0.489 | Vasodilator, coronary | 0.252 0.132 CHEMBL3526652 0.489 0.017 CHEMBL3527501 | CHEMBL3527501 | |
| 0.23 | 0.014 | 0.23 | Carbonic anhydrase XV inhibitor | |||
| 0.222 | 0.009 | 0.471 | NADH dehydrogenase inhibitor | 0.471 0.004 CHEMBL3526652 0.389 0.005 CHEMBL3527501 | CHEMBL3526652 | |
| 0.282 | 0.069 | 0.282 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.316 | 0.105 | 0.522 | Immunosuppressant | 0.413 0.058 CHEMBL3526652 0.522 0.027 CHEMBL3527501 0.208 0.188 CHEMBL3527502 | CHEMBL3527501 | |
| 0.346 | 0.141 | 0.346 | DNA polymerase beta inhibitor | |||
| 0.219 | 0.016 | 0.219 | Interleukin 1b antagonist | 0.169 0.029 CHEMBL3527501 | ||
| 0.212 | 0.009 | 0.212 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.22 | 0.017 | 0.22 | Arachidonic acid antagonist | 0.164 0.072 CHEMBL3527501 | ||
| 0.248 | 0.048 | 0.255 | DNA methyltransferase I inhibitor | 0.255 0.045 CHEMBL3527501 | CHEMBL3527501 | |
| 0.259 | 0.06 | 0.259 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.341 | 0.142 | 0.341 | MAP kinase 1 inhibitor | |||
| 0.208 | 0.009 | 0.208 | Creatine kinase inhibitor | |||
| 0.259 | 0.061 | 0.642 | DNA synthesis inhibitor | 0.642 0.006 CHEMBL3526652 0.387 0.023 CHEMBL3527501 | CHEMBL3526652 | |
| 0.307 | 0.11 | 0.307 | Calpain 2 inhibitor | |||
| 0.21 | 0.015 | 0.41 | Cyclooxygenase 3 inhibitor | 0.41 0.004 CHEMBL3527501 0.264 0.008 CHEMBL3527502 | CHEMBL3527501 | |
| 0.228 | 0.035 | 0.228 | Heat shock protein 90 alpha antagonist | |||
| 0.226 | 0.033 | 0.33 | Protein kinase stimulant | 0.33 0.013 CHEMBL3527501 | CHEMBL3527501 | |
| 0.191 | 0.005 | 0.191 | NMDA receptor agonist | 0.116 0.014 CHEMBL3527502 | ||
| 0.241 | 0.056 | 0.241 | Death-associated protein kinase 3 inhibitor | |||
| 0.202 | 0.018 | 0.202 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | |||
| 0.196 | 0.013 | 0.213 | Histidine decarboxylase inhibitor | 0.213 0.012 CHEMBL3527502 | CHEMBL3527502 | |
| 0.216 | 0.035 | 0.421 | Lipid peroxidase inhibitor | 0.421 0.009 CHEMBL3527501 0.166 0.058 CHEMBL3527502 | CHEMBL3527501 | |
| 0.206 | 0.026 | 0.206 | MAP kinase kinase inhibitor | |||
| 0.277 | 0.101 | 0.402 | Sodium/bile acid cotransporter inhibitor | 0.402 0.016 CHEMBL3527502 | CHEMBL3527502 | |
| 0.183 | 0.011 | 0.26 | Glutamate dehydrogenase inhibitor | 0.26 0.007 CHEMBL3526652 0.07 0.056 CHEMBL3527501 0.107 0.028 CHEMBL3527502 | CHEMBL3526652 | |
| 0.179 | 0.008 | 0.179 | MAP kinase kinase 1 inhibitor | |||
| 0.178 | 0.008 | 0.178 | Ca2+-transporting ATPase inhibitor | 0.16 0.023 CHEMBL3527501 | ||
| 0.187 | 0.018 | 0.187 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.201 | 0.034 | 0.201 | Cyclooxygenase 1 inhibitor | 0.169 0.048 CHEMBL3527501 | ||
| 0.208 | 0.042 | 0.208 | Protein kinase (CK1) gamma 3 inhibitor | |||
| 0.205 | 0.04 | 0.205 | Phospholipase A2 inhibitor | 0.133 0.096 CHEMBL3527501 0.2 0.043 CHEMBL3527502 | ||
| 0.226 | 0.063 | 0.372 | DNA methylase inhibitor | 0.372 0.014 CHEMBL3526652 0.289 0.031 CHEMBL3527501 | CHEMBL3526652 | |
| 0.17 | 0.008 | 0.17 | CC chemokine 6 receptor antagonist | 0.169 0.008 CHEMBL3527501 | ||
| 0.188 | 0.027 | 0.188 | Protein kinase (CK2) alpha inhibitor | |||
| 0.191 | 0.03 | 0.27 | Aldehyde dehydrogenase inhibitor | 0.27 0.015 CHEMBL3526652 0.107 0.086 CHEMBL3527501 | CHEMBL3526652 | |
| 0.226 | 0.068 | 0.556 | RNA-directed DNA polymerase inhibitor | 0.556 0.008 CHEMBL3526652 0.178 0.136 CHEMBL3527501 | CHEMBL3526652 | |
| 0.185 | 0.027 | 0.185 | Cathepsin H inhibitor | |||
| 0.165 | 0.01 | 0.165 | Argininosuccinate synthase inhibitor | 0.119 0.015 CHEMBL3526652 0.051 0.045 CHEMBL3527501 | ||
| 0.181 | 0.026 | 0.282 | Aminopeptidase B inhibitor | 0.282 0.01 CHEMBL3527502 | CHEMBL3527502 | |
| 0.166 | 0.01 | 0.188 | Glutamate decarboxylase inhibitor | 0.188 0.008 CHEMBL3527502 | CHEMBL3527502 | |
| 0.16 | 0.006 | 0.212 | Purinergic P2X1 antagonist | 0.212 0.003 CHEMBL3526652 0.081 0.025 CHEMBL3527501 | CHEMBL3526652 | |
| 0.203 | 0.052 | 0.203 | Tumour necrosis factor antagonist | |||
| 0.212 | 0.061 | 0.212 | I kappa B kinase epsilon inhibitor | |||
| 0.204 | 0.054 | 0.204 | Lipocortins synthesis antagonist | |||
| 0.175 | 0.024 | 0.175 | Protein kinase (CK2) inhibitor | |||
| 0.17 | 0.019 | 0.17 | Gastric antisecretory | |||
| 0.154 | 0.004 | 0.154 | NMDA receptor glycine site agonist | |||
| 0.2 | 0.051 | 0.2 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | |||
| 0.171 | 0.023 | 0.171 | Interleukin 8 antagonist | |||
| 0.17 | 0.022 | 0.17 | Potassium channel (Ca-activated) activator | |||
| 0.158 | 0.01 | 0.158 | Prostaglandin-E synthase inhibitor | |||
| 0.153 | 0.007 | 0.153 | GABA aminotransferase inhibitor | 0.109 0.021 CHEMBL3527501 | ||
| 0.183 | 0.038 | 0.305 | Cell wall synthesis inhibitor | 0.305 0.009 CHEMBL3527501 | CHEMBL3527501 | |
| 0.216 | 0.073 | 0.216 | Pyruvate kinase inhibitor | |||
| 0.158 | 0.018 | 0.158 | Protein kinase C delta inhibitor | 0.133 0.029 CHEMBL3527501 | ||
| 0.157 | 0.017 | 0.157 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.161 | 0.025 | 0.161 | Carbonic anhydrase III inhibitor | |||
| 0.143 | 0.007 | 0.143 | CDC25B inhibitor | 0.062 0.047 CHEMBL3527501 0.067 0.041 CHEMBL3527502 | ||
| 0.221 | 0.086 | 0.437 | Antiamyloidogenic | 0.437 0.023 CHEMBL3527501 0.423 0.025 CHEMBL3527502 | CHEMBL3527501 | |
| 0.156 | 0.021 | 0.156 | Uric acid excretion stimulant | 0.137 0.028 CHEMBL3527501 | ||
| 0.159 | 0.025 | 0.159 | TRPA1 agonist | |||
| 0.167 | 0.034 | 0.167 | Cystathionine beta-synthase inhibitor | |||
| 0.144 | 0.012 | 0.144 | Myeloperoxidase inhibitor | |||
| 0.15 | 0.018 | 0.836 | Phosphofructokinase-1 inhibitor | 0.836 0.001 CHEMBL3526652 0.198 0.011 CHEMBL3527501 | CHEMBL3526652 | |
| 0.16 | 0.028 | 0.182 | Heat shock protein 70 antagonist | 0.182 0.011 CHEMBL3526652 0.134 0.1 CHEMBL3527501 | CHEMBL3526652 | |
| 0.176 | 0.044 | 0.176 | Interleukin 1 antagonist | 0.109 0.106 CHEMBL3527501 | ||
| 0.195 | 0.064 | 0.195 | Dual specificity phosphatase 3 inhibitor | |||
| 0.151 | 0.021 | 0.151 | GABA C receptor rho-1 antagonist | |||
| 0.184 | 0.053 | 0.275 | ATPase inhibitor | 0.275 0.009 CHEMBL3527501 | CHEMBL3527501 | |
| 0.183 | 0.055 | 0.2 | Protein-tyrosine phosphatase inhibitor | 0.2 0.047 CHEMBL3527501 | CHEMBL3527501 | |
| 0.132 | 0.005 | 0.132 | Kainate receptor antagonist | |||
| 0.148 | 0.024 | 0.148 | Urease inhibitor | |||
| 0.198 | 0.076 | 0.198 | Insulin sensitizer | 0.17 0.107 CHEMBL3527502 | ||
| 0.146 | 0.026 | 0.596 | Beta glucuronidase inhibitor | 0.596 0.003 CHEMBL3527501 | CHEMBL3527501 | |
| 0.125 | 0.005 | 0.125 | Aconitate hydratase inhibitor | |||
| 0.142 | 0.023 | 0.142 | Carbonic anhydrase XIII inhibitor | 0.07 0.058 CHEMBL3527501 | ||
| 0.122 | 0.005 | 0.122 | Nicotinic acid receptor 2 agonist | |||
| 0.141 | 0.023 | 0.141 | Carbonic anhydrase VI inhibitor | |||
| 0.149 | 0.032 | 0.188 | Photosensitizer | 0.188 0.016 CHEMBL3527501 | CHEMBL3527501 | |
| 0.144 | 0.027 | 0.144 | Catalase inhibitor | 0.079 0.048 CHEMBL3527502 | ||
| 0.147 | 0.031 | 0.147 | GABA C receptor antagonist | |||
| 0.177 | 0.064 | 0.248 | Phospholipase C inhibitor | 0.181 0.059 CHEMBL3526652 0.248 0.025 CHEMBL3527502 | CHEMBL3527502 | |
| 0.168 | 0.056 | 0.419 | Amylase inhibitor | 0.419 0.008 CHEMBL3527501 | CHEMBL3527501 | |
| 0.116 | 0.004 | 0.116 | Dihydroorotate oxidase inhibitor | |||
| 0.231 | 0.121 | 0.231 | 12-Lipoxygenase inhibitor | |||
| 0.202 | 0.092 | 0.281 | Cyclic AMP phosphodiesterase inhibitor | 0.281 0.05 CHEMBL3527501 | CHEMBL3527501 | |
| 0.15 | 0.041 | 0.15 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.121 | 0.013 | 0.121 | D-Ala-D-Ala ligase inhibitor | |||
| 0.166 | 0.059 | 0.166 | Cyclooxygenase inhibitor | 0.141 0.077 CHEMBL3527501 | ||
| 0.198 | 0.092 | 0.199 | Nitric-oxide synthase stimulant | 0.199 0.091 CHEMBL3527501 | CHEMBL3527501 | |
| 0.3 | 0.194 | 0.425 | Caspase 9 stimulant | 0.425 0.097 CHEMBL3527501 | CHEMBL3527501 | |
| 0.144 | 0.039 | 0.144 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.195 | 0.091 | 0.195 | EphB2 antagonist | |||
| 0.106 | 0.004 | 0.106 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.174 | 0.072 | 0.174 | Dual specificity phosphatase inhibitor | |||
| 0.161 | 0.06 | 0.161 | GABA C receptor rho-2 antagonist | |||
| 0.111 | 0.011 | 0.111 | Potassium channel (ATP-sensitive) blocker | |||
| 0.105 | 0.009 | 0.105 | Glutamate (mGluR6) antagonist | |||
| 0.137 | 0.04 | 0.137 | Protein kinase C gamma inhibitor | 0.106 0.067 CHEMBL3527501 | ||
| 0.131 | 0.034 | 0.131 | DOPA decarboxylase inhibitor | |||
| 0.101 | 0.005 | 0.101 | Retinoid X alpha receptor agonist | |||
| 0.149 | 0.053 | 0.149 | Farnesoid X receptor antagonist | |||
| 0.103 | 0.007 | 0.103 | Cathepsin L2 inhibitor | |||
| 0.18 | 0.086 | 0.18 | Growth factor agonist | |||
| 0.099 | 0.005 | 0.099 | Adenine nucleotide translocase inhibitor | 0.058 0.032 CHEMBL3526652 0.091 0.005 CHEMBL3527501 0.08 0.009 CHEMBL3527502 | ||
| 0.097 | 0.003 | 0.097 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.157 | 0.064 | 0.157 | Protein kinase (CK1) gamma 1 inhibitor | |||
| 0.26 | 0.168 | 0.58 | Antibacterial | 0.285 0.147 CHEMBL3526652 0.58 0.023 CHEMBL3527501 | CHEMBL3527501 | |
| 0.232 | 0.14 | 0.477 | Interleukin 2 agonist | 0.477 0.011 CHEMBL3527501 0.32 0.061 CHEMBL3527502 | CHEMBL3527501 | |
| 0.099 | 0.008 | 0.099 | Nicotinic acid receptor 1 agonist | |||
| 0.095 | 0.005 | 0.095 | Retinoid X receptor agonist | |||
| 0.097 | 0.009 | 0.097 | H+/K+-transporting ATPase inhibitor | |||
| 0.093 | 0.005 | 0.093 | Nicotinic acid receptor agonist | |||
| 0.141 | 0.053 | 0.141 | Anesthetic local | |||
| 0.131 | 0.045 | 0.314 | Mucolytic | 0.111 0.064 CHEMBL3526652 0.148 0.033 CHEMBL3527501 0.314 0.004 CHEMBL3527502 | CHEMBL3527502 | |
| 0.11 | 0.023 | 0.134 | Aminopeptidase I inhibitor | 0.134 0.016 CHEMBL3527502 | CHEMBL3527502 | |
| 0.102 | 0.016 | 0.185 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.185 0.004 CHEMBL3526652 0.058 0.041 CHEMBL3527501 | CHEMBL3526652 | |
| 0.232 | 0.147 | 0.232 | Thioredoxin glutathione reductase inhibitor | |||
| 0.117 | 0.033 | 0.117 | ABCA1 expression enhancer | |||
| 0.107 | 0.023 | 0.107 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.112 | 0.029 | 0.112 | Bile acid receptor antagonist | |||
| 0.098 | 0.016 | 0.098 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.16 | 0.079 | 0.163 | Neurotensin receptor agonist | 0.163 0.074 CHEMBL3527502 | CHEMBL3527502 | |
| 0.118 | 0.037 | 0.265 | Alcohol dehydrogenase inhibitor | 0.265 0.007 CHEMBL3526652 | CHEMBL3526652 | |
| 0.152 | 0.072 | 0.152 | Heat shock protein 90 antagonist | |||
| 0.14 | 0.062 | 0.14 | NADPH oxidase inhibitor | |||
| 0.095 | 0.017 | 0.574 | Acyl-CoA dehydrogenase inhibitor | 0.574 0 CHEMBL3526652 | CHEMBL3526652 | |
| 0.156 | 0.078 | 0.156 | Polo-like kinase-3 inhibitor | |||
| 0.132 | 0.054 | 0.193 | Protein-tyrosine phosphatase 1B inhibitor | 0.193 0.031 CHEMBL3527501 | CHEMBL3527501 | |
| 0.177 | 0.1 | 0.177 | Platelet aggregation inhibitor | 0.164 0.113 CHEMBL3527502 | ||
| 0.097 | 0.023 | 0.097 | Glycine receptor agonist | 0.067 0.06 CHEMBL3527501 | ||
| 0.085 | 0.012 | 0.085 | Protein kinase C theta inhibitor | |||
| 0.143 | 0.071 | 0.143 | Glycogen synthase kinase-3 alpha inhibitor | |||
| 0.117 | 0.046 | 0.117 | Platelet activating factor alpha antagonist | |||
| 0.217 | 0.146 | 0.217 | Prostaglandin dehydrogenase inhibitor | |||
| 0.183 | 0.112 | 0.183 | Aryl hydrocarbon receptor agonist | |||
| 0.158 | 0.089 | 0.158 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.114 | 0.047 | 0.114 | MAP kinase 8 inhibitor | |||
| 0.072 | 0.006 | 0.072 | Retinoic acid alpha receptor agonist | |||
| 0.143 | 0.079 | 0.143 | MAP kinase 3 inhibitor | |||
| 0.074 | 0.01 | 0.074 | Leukotriene C antagonist | |||
| 0.162 | 0.098 | 0.514 | Hepatoprotectant | 0.153 0.106 CHEMBL3526652 0.514 0.006 CHEMBL3527501 0.354 0.018 CHEMBL3527502 | CHEMBL3527501 | |
| 0.083 | 0.019 | 0.083 | Prostaglandin E2 antagonist | |||
| 0.157 | 0.094 | 0.157 | Amyloid beta precursor protein antagonist | |||
| 0.121 | 0.058 | 0.121 | Caspase 3 inhibitor | |||
| 0.216 | 0.154 | 0.62 | Transcription factor NF kappa B inhibitor | 0.62 0.029 CHEMBL3527501 0.34 0.08 CHEMBL3527502 | CHEMBL3527501 | |
| 0.075 | 0.014 | 0.965 | Purinergic P2Y antagonist | 0.965 0 CHEMBL3526652 | CHEMBL3526652 | |
| 0.145 | 0.085 | 0.145 | CF transmembrane conductance regulator agonist | 0.144 0.087 CHEMBL3527501 | ||
| 0.092 | 0.032 | 0.092 | CDC25A inhibitor | 0.079 0.045 CHEMBL3527502 | ||
| 0.093 | 0.034 | 0.093 | Estrogen-related receptor beta agonist | |||
| 0.102 | 0.042 | 0.102 | Ornithine decarboxylase inhibitor | |||
| 0.077 | 0.018 | 0.18 | Phosphorylase inhibitor | 0.059 0.025 CHEMBL3526652 0.18 0.006 CHEMBL3527501 | CHEMBL3527501 | |
| 0.084 | 0.025 | 0.086 | Protein kinase C beta inhibitor | 0.086 0.023 CHEMBL3527501 | CHEMBL3527501 | |
| 0.102 | 0.044 | 0.102 | Histamine N-methyltransferase inhibitor | |||
| 0.187 | 0.129 | 0.705 | Immunostimulant | 0.705 0.007 CHEMBL3526652 0.519 0.027 CHEMBL3527501 0.491 0.03 CHEMBL3527502 | CHEMBL3526652 | |
| 0.08 | 0.022 | 0.181 | Ornithine carbamoyltransferase inhibitor | 0.181 0.008 CHEMBL3526652 0.067 0.027 CHEMBL3527502 | CHEMBL3526652 | |
| 0.089 | 0.031 | 0.089 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.246 | 0.189 | 0.246 | Transcription factor inhibitor | |||
| 0.165 | 0.108 | 0.504 | Interleukin antagonist | 0.504 0.019 CHEMBL3527502 | CHEMBL3527502 | |
| 0.064 | 0.009 | 0.064 | GABA uptake inhibitor | |||
| 0.08 | 0.025 | 0.08 | NMDA 2C receptor antagonist | |||
| 0.112 | 0.058 | 0.112 | Interleukin 2 antagonist | |||
| 0.072 | 0.018 | 0.072 | Diacylglycerol O-acyltransferase inhibitor | |||
| 0.124 | 0.071 | 0.124 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.233 | 0.18 | 0.233 | 15-Lipoxygenase inhibitor | |||
| 0.071 | 0.018 | 0.071 | Plasminogen activator inhibitor antagonist | |||
| 0.119 | 0.068 | 0.619 | Adenylate cyclase inhibitor | 0.619 0.003 CHEMBL3526652 | CHEMBL3526652 | |
| 0.072 | 0.021 | 0.072 | Peroxisome proliferator-activated receptor alpha agonist | |||
| 0.106 | 0.055 | 0.106 | Anabolic | |||
| 0.19 | 0.14 | 0.19 | Streptokinase A inhibitor | |||
| 0.061 | 0.011 | 0.061 | Guanylate cyclase inhibitor | 0.043 0.029 CHEMBL3527501 | ||
| 0.095 | 0.046 | 0.095 | Bcr-Abl kinase inhibitor | |||
| 0.065 | 0.015 | 0.065 | NMDA receptor subunit 3A antagonist | |||
| 0.136 | 0.087 | 0.254 | Thiol protease inhibitor | 0.254 0.026 CHEMBL3527502 | CHEMBL3527502 | |
| 0.135 | 0.086 | 0.135 | MAP3K9 inhibitor | |||
| 0.064 | 0.015 | 0.064 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.108 | 0.06 | 0.197 | Mediator release inhibitor | 0.197 0.015 CHEMBL3527501 | CHEMBL3527501 | |
| 0.056 | 0.008 | 0.056 | Retinoid X receptor antagonist | |||
| 0.104 | 0.057 | 0.159 | Xanthine oxidase inhibitor | 0.159 0.031 CHEMBL3527501 | CHEMBL3527501 | |
| 0.064 | 0.017 | 0.064 | NMDA receptor subunit 3B antagonist | |||
| 0.055 | 0.009 | 0.055 | Glutamate (mGluR8) agonist | |||
| 0.051 | 0.005 | 0.051 | Retinoid X gamma receptor agonist | |||
| 0.138 | 0.092 | 0.138 | Src kinase inhibitor | |||
| 0.052 | 0.007 | 0.052 | Purinergic P2Y14 antagonist | |||
| 0.173 | 0.128 | 0.173 | ErbB-1 antagonist | |||
| 0.084 | 0.039 | 0.084 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.076 | 0.032 | 0.076 | Glutamate (mGluR7) antagonist | |||
| 0.063 | 0.018 | 0.063 | CXC chemokine 1 receptor antagonist | |||
| 0.163 | 0.119 | 0.163 | Neurotrophic factor enhancer | 0.155 0.13 CHEMBL3527501 | ||
| 0.049 | 0.006 | 0.049 | NMDA receptor glycine site antagonist | |||
| 0.083 | 0.039 | 0.083 | MAP kinase kinase 7 inhibitor | |||
| 0.253 | 0.21 | 0.699 | Cyclophilin D inhibitor | 0.699 0.014 CHEMBL3527501 | CHEMBL3527501 | |
| 0.064 | 0.022 | 0.064 | Pregnane X receptor antagonist | |||
| 0.124 | 0.082 | 0.124 | Lck kinase inhibitor | |||
| 0.071 | 0.029 | 0.071 | Maillard reaction inhibitor | |||
| 0.093 | 0.052 | 0.093 | NMDA receptor antagonist | |||
| 0.049 | 0.007 | 0.049 | Retinoid X alpha receptor antagonist | |||
| 0.159 | 0.117 | 0.159 | Focal adhesion kinase 2 inhibitor | |||
| 0.116 | 0.074 | 0.116 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.062 | 0.021 | 0.062 | Topoisomerase II beta inhibitor | |||
| 0.046 | 0.005 | 0.046 | Retinoid X beta receptor agonist | |||
| 0.064 | 0.023 | 0.064 | Sphingosine 1-phosphate receptor 1 antagonist | |||
| 0.055 | 0.014 | 0.055 | Dihydropteroate synthase inhibitor | |||
| 0.098 | 0.057 | 0.101 | Interleukin 12 antagonist | 0.101 0.052 CHEMBL3527501 | CHEMBL3527501 | |
| 0.062 | 0.022 | 0.062 | Potassium channel (Inward rectifier) blocker | |||
| 0.045 | 0.004 | 0.045 | Nicotinic acid receptor 2 antagonist | |||
| 0.09 | 0.051 | 0.09 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.125 | 0.085 | 0.125 | Protein kinase (CK1) gamma inhibitor | |||
| 0.12 | 0.081 | 0.12 | Antibacterial (Helicobacter pylori) | |||
| 0.104 | 0.065 | 0.343 | Expectorant | 0.343 0.006 CHEMBL3526652 0.276 0.01 CHEMBL3527501 0.326 0.007 CHEMBL3527502 | CHEMBL3526652 | |
| 0.122 | 0.083 | 0.122 | Protein-tyrosine kinase Lyn inhibitor | |||
| 0.207 | 0.169 | 0.594 | Antithrombotic | 0.387 0.053 CHEMBL3526652 0.594 0.017 CHEMBL3527501 | CHEMBL3527501 | |
| 0.085 | 0.048 | 0.085 | T cell inhibitor | |||
| 0.046 | 0.009 | 0.046 | Uridine phosphorylase inhibitor | 0.038 0.013 CHEMBL3527501 | ||
| 0.076 | 0.04 | 0.076 | Carbonic anhydrase VA inhibitor | |||
| 0.08 | 0.043 | 0.08 | GABA B receptor agonist | |||
| 0.043 | 0.007 | 0.043 | Glutamate (mGluR3) agonist | |||
| 0.093 | 0.057 | 0.093 | Potassium channel activator | |||
| 0.048 | 0.012 | 0.048 | Leukotriene C4 antagonist | |||
| 0.161 | 0.126 | 0.299 | Hypolipemic | 0.299 0.049 CHEMBL3527501 | CHEMBL3527501 | |
| 0.041 | 0.007 | 0.041 | Retinoic acid receptor agonist | |||
| 0.055 | 0.022 | 0.055 | Thymidylate synthase inhibitor | 0.054 0.023 CHEMBL3527502 | ||
| 0.186 | 0.154 | 0.186 | Transcription factor STAT3 inhibitor | |||
| 0.188 | 0.156 | 0.188 | Transcription factor STAT inhibitor | |||
| 0.047 | 0.015 | 0.047 | Potassium channel Kv1.1 blocker | |||
| 0.039 | 0.007 | 0.039 | Kainate receptor 5 antagonist | |||
| 0.084 | 0.053 | 0.084 | Adrenaline agonist | |||
| 0.174 | 0.143 | 0.174 | Calpain inhibitor | |||
| 0.115 | 0.085 | 0.115 | Cyclooxygenase 2 inhibitor | |||
| 0.038 | 0.008 | 0.038 | Kainate receptor 1 antagonist | |||
| 0.047 | 0.017 | 0.047 | Kainate receptor agonist | |||
| 0.057 | 0.028 | 0.105 | Heparanase inhibitor | 0.105 0.004 CHEMBL3527501 | CHEMBL3527501 | |
| 0.056 | 0.027 | 0.056 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.033 | 0.004 | 0.033 | Nicotinic acid receptor 1 antagonist | |||
| 0.045 | 0.016 | 0.048 | Fumarate hydratase inhibitor | 0.048 0.014 CHEMBL3526652 | CHEMBL3526652 | |
| 0.042 | 0.014 | 0.089 | Purinergic P2Y2 antagonist | 0.089 0.005 CHEMBL3526652 | CHEMBL3526652 | |
| 0.07 | 0.042 | 0.07 | Carbonic anhydrase V inhibitor | |||
| 0.033 | 0.005 | 0.033 | Retinoic acid beta receptor agonist | |||
| 0.048 | 0.02 | 0.048 | Urate transporter 1 inhibitor | |||
| 0.149 | 0.121 | 0.149 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | |||
| 0.04 | 0.014 | 0.04 | Peroxisome proliferator-activated receptor delta antagonist | |||
| 0.029 | 0.004 | 0.029 | Retinoid X beta receptor antagonist | |||
| 0.057 | 0.032 | 0.057 | DNA helicase inhibitor | |||
| 0.06 | 0.035 | 0.06 | Carbonic anhydrase VB inhibitor | |||
| 0.053 | 0.029 | 0.074 | Carbonic anhydrase XIV inhibitor | 0.074 0.019 CHEMBL3527501 | CHEMBL3527501 | |
| 0.04 | 0.016 | 0.04 | Glutamate (mGluR8) antagonist | 0.04 0.016 CHEMBL3527502 | ||
| 0.03 | 0.006 | 0.03 | Retinoic acid alpha receptor antagonist | |||
| 0.2 | 0.176 | 0.334 | Vasodilator, peripheral | 0.334 0.081 CHEMBL3527501 | CHEMBL3527501 | |
| 0.03 | 0.006 | 0.03 | Retinoic acid gamma receptor agonist | |||
| 0.105 | 0.081 | 0.105 | Cholesterol synthesis inhibitor | |||
| 0.042 | 0.019 | 0.042 | Glutamate (mGluR3) antagonist | |||
| 0.027 | 0.004 | 0.027 | Histone-lysine N-methyltransferase EZH2 inhibitor | |||
| 0.065 | 0.042 | 0.101 | Neuraminidase (influenza) inhibitor | 0.101 0.016 CHEMBL3527501 | CHEMBL3527501 | |
| 0.047 | 0.024 | 0.047 | Glutamate (mGluR group III) antagonist | |||
| 0.032 | 0.01 | 0.032 | Retinoid X gamma receptor antagonist | |||
| 0.048 | 0.027 | 0.058 | Neuraminidase (Influenza A) inhibitor | 0.058 0.014 CHEMBL3527501 | CHEMBL3527501 | |
| 0.046 | 0.025 | 0.046 | Glutamate (mGluR4) antagonist | |||
| 0.05 | 0.03 | 0.076 | Adenosine deaminase inhibitor | 0.076 0.01 CHEMBL3526652 | CHEMBL3526652 | |
| 0.045 | 0.024 | 0.045 | Angiotensin AT1 receptor antagonist | |||
| 0.026 | 0.007 | 0.026 | Retinoic acid receptor antagonist | |||
| 0.023 | 0.004 | 0.023 | Thrombopoietin agonist | |||
| 0.049 | 0.031 | 0.073 | Glucose-6-phosphate isomerase inhibitor | 0.073 0.011 CHEMBL3527501 | CHEMBL3527501 | |
| 0.045 | 0.026 | 0.045 | Nerve growth factor antagonist | |||
| 0.032 | 0.014 | 0.032 | NMDA 2D receptor antagonist | |||
| 0.113 | 0.096 | 0.113 | Alkaline phosphatase inhibitor | |||
| 0.037 | 0.02 | 0.037 | Free fatty acid receptor 1 antagonist | |||
| 0.045 | 0.028 | 0.045 | Glutamate (mGluR group III) agonist | |||
| 0.041 | 0.025 | 0.043 | Membrane dipeptidase inhibitor | 0.043 0.022 CHEMBL3527502 | CHEMBL3527502 | |
| 0.05 | 0.034 | 0.05 | Factor III inhibitor | |||
| 0.067 | 0.052 | 0.067 | ZAP-70 protein tyrosine kinase inhibitor | |||
| 0.03 | 0.015 | 0.03 | DNA polymerase III inhibitor | |||
| 0.059 | 0.045 | 0.08 | Neuraminidase inhibitor | 0.08 0.026 CHEMBL3527501 | CHEMBL3527501 | |
| 0.199 | 0.185 | 0.199 | Beta lactamase inhibitor | |||
| 0.058 | 0.045 | 0.271 | Carbamoyl phosphate synthetase inhibitor | 0.271 0.005 CHEMBL3526652 | CHEMBL3526652 | |
| 0.06 | 0.047 | 0.06 | HIV-1 integrase (3'-Processing) inhibitor | |||
| 0.038 | 0.026 | 0.038 | Farnesoid X receptor agonist | |||
| 0.125 | 0.113 | 0.125 | Adenylate cyclase stimulant | |||
| 0.027 | 0.014 | 0.029 | Vanilloid 2 agonist | 0.029 0.011 CHEMBL3527501 | CHEMBL3527501 | |
| 0.065 | 0.053 | 0.065 | Peroxisome proliferator-activated receptor gamma agonist | |||
| 0.054 | 0.042 | 0.054 | Xanthine dehydrogenase inhibitor | |||
| 0.026 | 0.014 | 0.026 | Glutamate (mGluR1) agonist | |||
| 0.185 | 0.173 | 0.185 | MAP kinase kinase 3 inhibitor | |||
| 0.028 | 0.017 | 0.028 | Prostaglandin EP4 antagonist | |||
| 0.032 | 0.021 | 0.032 | ATP citrate lysase inhibitor | |||
| 0.033 | 0.022 | 0.033 | Protein kinase C beta II inhibitor | 0.031 0.027 CHEMBL3527501 | ||
| 0.031 | 0.02 | 0.031 | Elastase 2B inhibitor | |||
| 0.031 | 0.02 | 0.031 | Elastase 3B inhibitor | |||
| 0.031 | 0.02 | 0.031 | Elastase 3A inhibitor | |||
| 0.016 | 0.005 | 0.016 | Retinoic acid beta receptor antagonist | |||
| 0.075 | 0.065 | 0.118 | Glycine receptor antagonist | 0.118 0.019 CHEMBL3527501 | CHEMBL3527501 | |
| 0.014 | 0.005 | 0.014 | Retinoic acid receptor gamma antagonist | |||
| 0.035 | 0.026 | 0.035 | Kainate receptor 2 antagonist | |||
| 0.037 | 0.029 | 0.037 | Alpha 1d adrenoreceptor agonist | |||
| 0.022 | 0.013 | 0.022 | Neuraminidase (Influenza B) inhibitor | |||
| 0.036 | 0.027 | 0.036 | Integrin alpha2 antagonist | |||
| 0.049 | 0.041 | 0.049 | Prostaglandin antagonist | |||
| 0.076 | 0.068 | 0.273 | Glutathione S-transferase inhibitor | 0.273 0.003 CHEMBL3527502 | CHEMBL3527502 | |
| 0.052 | 0.044 | 0.247 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.247 0.005 CHEMBL3526652 0.071 0.025 CHEMBL3527501 | CHEMBL3526652 | |
| 0.023 | 0.015 | 0.023 | Glutamate (mGluR1a) agonist | |||
| 0.104 | 0.096 | 0.104 | Transcription factor STAT6 inhibitor | |||
| 0.036 | 0.029 | 0.036 | TRPM8 blocker | |||
| 0.051 | 0.044 | 0.051 | Sphingosine 1-phosphate receptor 5 agonist | |||
| 0.021 | 0.015 | 0.021 | Peroxisome proliferator-activated receptor alpha antagonist | |||
| 0.064 | 0.058 | 0.064 | MDM2 inhibitor | |||
| 0.089 | 0.083 | 0.089 | Falcipain 3 inhibitor | |||
| 0.014 | 0.008 | 0.014 | DNA polymerase III polC-type inhibitor | |||
| 0.033 | 0.027 | 0.033 | Angiotensin II receptor antagonist | |||
| 0.049 | 0.043 | 0.049 | Thromboxane antagonist | |||
| 0.183 | 0.177 | 0.183 | Thyroid hormone antagonist | |||
| 0.062 | 0.056 | 0.062 | Potassium channel large-conductance Ca-activated activator | |||
| 0.009 | 0.004 | 0.009 | DNA topoisomerase III inhibitor | |||
| 0.049 | 0.044 | 0.049 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.089 | 0.084 | 0.213 | Monophenol monooxygenase inhibitor | 0.213 0.03 CHEMBL3527501 | CHEMBL3527501 | |
| 0.025 | 0.02 | 0.025 | CXC chemokine 2 receptor antagonist | |||
| 0.025 | 0.02 | 0.025 | Integrin alpha2beta1 antagonist | |||
| 0.034 | 0.029 | 0.034 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.032 | 0.027 | 0.032 | Protein kinase (CK2) beta inhibitor | |||
| 0.045 | 0.04 | 0.045 | Thromboxane A2 antagonist | |||
| 0.022 | 0.017 | 0.022 | Beta 1 adrenoreceptor agonist | |||
| 0.038 | 0.034 | 0.1 | Thymidine kinase inhibitor | 0.1 0.006 CHEMBL3526652 | CHEMBL3526652 | |
| 0.025 | 0.02 | 0.025 | Kynurenine 3 monooxygenase inhibitor | |||
| 0.046 | 0.042 | 0.046 | NMDA 2A receptor antagonist | |||
| 0.031 | 0.027 | 0.031 | Peroxisome proliferator-activated receptor delta agonist | |||
| 0.035 | 0.031 | 0.035 | DNA gyrase subunit B inhibitor | |||
| 0.025 | 0.022 | 0.025 | Calcium-sensing receptor agonist | 0.025 0.022 CHEMBL3527502 | ||
| 0.017 | 0.015 | 0.209 | Methylmalonyl-CoA mutase inhibitor | 0.209 0 CHEMBL3526652 | CHEMBL3526652 | |
| 0.012 | 0.009 | 0.012 | Glutamate (mGluR6) agonist | |||
| 0.024 | 0.022 | 0.024 | Thyroid hormone agonist | |||
| 0.09 | 0.088 | 0.123 | Folate antagonist | 0.123 0.037 CHEMBL3527502 | CHEMBL3527502 | |
| 0.025 | 0.023 | 0.025 | Thymidine kinase (Herpes simplex virus 1) inhibitor | |||
| 0.031 | 0.03 | 0.165 | Phosphoglycerate kinase inhibitor | 0.165 0.004 CHEMBL3526652 | CHEMBL3526652 | |
| 0.075 | 0.074 | 0.075 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | |||
| 0.046 | 0.045 | 0.046 | CD45 antagonist | |||
| 0.031 | 0.03 | 0.031 | Glutamate (mGluR4) agonist | |||
| 0.111 | 0.111 | 0.125 | Vanilloid 1 agonist | 0.113 0.105 CHEMBL3527501 0.125 0.077 CHEMBL3527502 | CHEMBL3527502 | |
| 0.093 | 0.092 | 0.093 | Protein kinase (CK1) gamma 2 inhibitor | |||
| 0.092 | 0.092 | 0.142 | Factor V inhibitor | 0.142 0.023 CHEMBL3527502 | CHEMBL3527502 | |
| 0.044 | 0.048 | 0.094 | Factor IXa inhibitor | 0.094 0.011 CHEMBL3527501 | CHEMBL3527501 | |
| 0.087 | 0.092 | 0.268 | AMP-activated protein kinase stimulant | 0.268 0.006 CHEMBL3527501 | CHEMBL3527501 | |
| 0.122 | 0.131 | 0.176 | Melanin inhibitor | 0.176 0.054 CHEMBL3527501 | CHEMBL3527501 | |
| 0.152 | 0.163 | 0.611 | Antioxidant | 0.611 0.011 CHEMBL3527501 0.222 0.1 CHEMBL3527502 | CHEMBL3527501 | |
| 0.08 | 0.091 | 0.098 | Glutamate release inhibitor | 0.098 0.046 CHEMBL3527501 | CHEMBL3527501 | |
| 0.039 | 0.053 | 0.074 | Carnitine palmitoyltransferase 1B inhibitor | 0.074 0.009 CHEMBL3526652 | CHEMBL3526652 | |
| 0.092 | 0.106 | 0.173 | Microtubule formation inhibitor | 0.173 0.028 CHEMBL3527501 | CHEMBL3527501 | |
| 0.01 | 0.026 | 0.021 | Ileal bile acid transport inhibitor | 0.021 0.008 CHEMBL3527501 | CHEMBL3527501 | |
| 0.01 | 0.027 | 0.017 | Aminopeptidase A inhibitor | 0.017 0.014 CHEMBL3527502 | CHEMBL3527502 | |
| 0.035 | 0.052 | 0.074 | Mannosidase inhibitor | 0.074 0.01 CHEMBL3527501 | CHEMBL3527501 | |
| 0.042 | 0.06 | 0.121 | Protein kinase C eta inhibitor | 0.121 0.012 CHEMBL3527501 | CHEMBL3527501 | |
| 0.018 | 0.038 | 0.025 | Lysine carboxypeptidase inhibitor | 0.025 0.021 CHEMBL3527502 | CHEMBL3527502 | |
| 0.086 | 0.106 | 0.143 | Histone deacetylase class III inhibitor | 0.143 0.05 CHEMBL3527502 | CHEMBL3527502 | |
| 0.106 | 0.128 | 0.291 | Thrombolytic | 0.291 0.025 CHEMBL3527501 0.28 0.027 CHEMBL3527502 | CHEMBL3527501 | |
| 0.044 | 0.067 | 0.061 | Carbonic anhydrase stimulant | 0.061 0.039 CHEMBL3527502 | CHEMBL3527502 | |
| 0.011 | 0.037 | 0.017 | Telomerase stimulant | 0.017 0.013 CHEMBL3527501 | CHEMBL3527501 | |
| 0.03 | 0.056 | 0.047 | Carbonic anhydrase XII inhibitor | 0.047 0.041 CHEMBL3527501 | CHEMBL3527501 | |
| 0.018 | 0.047 | 0.031 | Arginase inhibitor | 0.031 0.03 CHEMBL3527502 | CHEMBL3527502 | |
| 0.006 | 0.037 | 0.01 | Purinergic P2Y2 agonist | 0.01 0.008 CHEMBL3527501 | CHEMBL3527501 | |
| 0.079 | 0.113 | 0.463 | DNA polymerase I inhibitor | 0.463 0.004 CHEMBL3526652 0.189 0.032 CHEMBL3527501 | CHEMBL3526652 | |
| 0.013 | 0.047 | 0.028 | Antibiotic Anthracycline-like | 0.028 0.004 CHEMBL3527501 | CHEMBL3527501 | |
| 0.079 | 0.113 | 0.118 | Phosphodiesterase 6D inhibitor | 0.118 0.027 CHEMBL3527501 | CHEMBL3527501 | |
| 0.09 | 0.125 | 0.185 | Toll-Like receptor 2 antagonist | 0.185 0.031 CHEMBL3527502 | CHEMBL3527502 | |
| 0.039 | 0.074 | 0.077 | Alpha-mannosidase inhibitor | 0.077 0.012 CHEMBL3527501 | CHEMBL3527501 | |
| 0.009 | 0.046 | 0.048 | Purinergic P2Y1 agonist | 0.048 0.002 CHEMBL3526652 | CHEMBL3526652 | |
| 0.091 | 0.135 | 0.124 | Interleukin 4 antagonist | 0.124 0.079 CHEMBL3527501 | CHEMBL3527501 | |
| 0.01 | 0.054 | 0.073 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.073 0.005 CHEMBL3526652 | CHEMBL3526652 | |
| 0.048 | 0.096 | 0.074 | Interferon inducer | 0.074 0.03 CHEMBL3527501 | CHEMBL3527501 | |
| 0.149 | 0.198 | 0.364 | Peptidyltransferase inhibitor | 0.194 0.108 CHEMBL3526652 0.364 0.01 CHEMBL3527501 0.261 0.043 CHEMBL3527502 | CHEMBL3527501 | |
| 0.077 | 0.126 | 0.188 | Alkylator | 0.188 0.03 CHEMBL3527501 | CHEMBL3527501 | |
| 0.025 | 0.075 | 0.033 | Protein kinase C beta I inhibitor | 0.033 0.024 CHEMBL3527501 | CHEMBL3527501 | |
| 0.049 | 0.099 | 0.431 | Telomerase inhibitor | 0.28 0.007 CHEMBL3526652 0.431 0.004 CHEMBL3527502 | CHEMBL3527502 | |
| 0.045 | 0.096 | 0.095 | Na+ K+ transporting ATPase inhibitor | 0.095 0.037 CHEMBL3527501 | CHEMBL3527501 | |
| 0.019 | 0.08 | 0.061 | Inosine monophosphate dehydrogenase inhibitor | 0.061 0.01 CHEMBL3526652 | CHEMBL3526652 | |
| 0.064 | 0.125 | 0.185 | Transcription factor NF kappa B stimulant | 0.126 0.023 CHEMBL3526652 0.185 0.01 CHEMBL3527501 0.104 0.035 CHEMBL3527502 | CHEMBL3527501 | |
| 0.053 | 0.117 | 0.088 | Interferon agonist | 0.088 0.041 CHEMBL3527501 | CHEMBL3527501 | |
| 0.019 | 0.085 | 0.141 | Toll-Like receptor 2 agonist | 0.141 0.012 CHEMBL3527502 | CHEMBL3527502 | |
| 0.032 | 0.098 | 0.347 | Selectin antagonist | 0.347 0.004 CHEMBL3527501 0.076 0.039 CHEMBL3527502 | CHEMBL3527501 | |
| 0.072 | 0.139 | 0.18 | Beta amyloid protein antagonist | 0.18 0.024 CHEMBL3527501 0.136 0.051 CHEMBL3527502 | CHEMBL3527501 | |
| 0.124 | 0.192 | 0.278 | Spasmolytic | 0.278 0.079 CHEMBL3527501 | CHEMBL3527501 | |
| 0.15 | 0.219 | 0.198 | Hypoxia-inducible factor 1 alpha inhibitor | 0.198 0.154 CHEMBL3527501 | CHEMBL3527501 | |
| 0.167 | 0.236 | 0.518 | Apoptosis antagonist | 0.215 0.161 CHEMBL3526652 0.518 0.018 CHEMBL3527501 0.42 0.033 CHEMBL3527502 | CHEMBL3527501 | |
| 0.011 | 0.081 | 0.063 | Sodium/glucose cotransporter 2 inhibitor | 0.063 0.005 CHEMBL3527501 | CHEMBL3527501 | |
| 0.007 | 0.08 | 0.021 | Adenosine kinase inhibitor | 0.021 0.015 CHEMBL3526652 | CHEMBL3526652 | |
| 0.093 | 0.167 | 0.741 | Angiogenesis stimulant | 0.741 0.004 CHEMBL3527501 0.326 0.04 CHEMBL3527502 | CHEMBL3527501 | |
| 0.014 | 0.088 | 0.061 | Sodium/glucose cotransporter inhibitor | 0.061 0.004 CHEMBL3527501 | CHEMBL3527501 | |
| 0.029 | 0.107 | 0.188 | Purinergic P2X2 antagonist | 0.188 0.005 CHEMBL3526652 | CHEMBL3526652 | |
| 0.116 | 0.198 | 0.539 | Free radical scavenger | 0.539 0.013 CHEMBL3527501 0.183 0.112 CHEMBL3527502 | CHEMBL3527501 | |
| 0.006 | 0.089 | 0.078 | Purinergic P2T antagonist | 0.078 0.006 CHEMBL3526652 | CHEMBL3526652 | |
| 0.012 | 0.096 | 0.031 | Protocollagen prolyl hydroxylase inhibitor | 0.031 0.014 CHEMBL3527502 | CHEMBL3527502 | |
| 0.094 | 0.18 | 0.266 | NOS3 expression enhancer | 0.266 0.023 CHEMBL3527501 | CHEMBL3527501 | |
| 0.064 | 0.15 | 0.201 | Hematopoietic | 0.103 0.033 CHEMBL3526652 0.201 0.01 CHEMBL3527502 | CHEMBL3527502 | |
| 0.019 | 0.106 | 0.348 | Antimetabolite | 0.348 0.004 CHEMBL3526652 | CHEMBL3526652 | |
| 0.077 | 0.164 | 0.217 | Cell adhesion inhibitor | 0.217 0.021 CHEMBL3527501 | CHEMBL3527501 | |
| 0.008 | 0.097 | 0.11 | Purinergic P2X agonist | 0.11 0.003 CHEMBL3526652 | CHEMBL3526652 | |
| 0.096 | 0.184 | 0.215 | Hemostatic | 0.215 0.028 CHEMBL3527501 | CHEMBL3527501 | |
| 0.005 | 0.095 | 0.054 | Neutral endopeptidase inhibitor | 0.054 0.007 CHEMBL3527502 | CHEMBL3527502 | |
| 0.018 | 0.108 | 0.145 | Ribonucleoside-diphosphate reductase inhibitor | 0.145 0.012 CHEMBL3526652 0.049 0.042 CHEMBL3527502 | CHEMBL3526652 | |
| 0.017 | 0.11 | 0.177 | Ribonucleotide reductase inhibitor | 0.177 0.009 CHEMBL3526652 0.048 0.044 CHEMBL3527502 | CHEMBL3526652 | |
| 0.031 | 0.126 | 0.085 | HIV-1 reverse transcriptase inhibitor | 0.085 0.039 CHEMBL3526652 | CHEMBL3526652 | |
| 0.035 | 0.133 | 0.147 | Angiotensin-converting enzyme inhibitor | 0.147 0.005 CHEMBL3527502 | CHEMBL3527502 | |
| 0.059 | 0.159 | 0.087 | Nitric-oxide synthase inhibitor | 0.087 0.083 CHEMBL3527502 | CHEMBL3527502 | |
| 0.008 | 0.116 | 0.075 | Leukotriene A4 hydrolase inhibitor | 0.075 0.01 CHEMBL3527502 | CHEMBL3527502 | |
| 0.016 | 0.129 | 0.043 | Integrin alpha5beta1 antagonist | 0.043 0.025 CHEMBL3527502 | CHEMBL3527502 | |
| 0.051 | 0.164 | 0.361 | Aminoacyl-tRNA synthetase inhibitor | 0.361 0.005 CHEMBL3526652 0.095 0.051 CHEMBL3527502 | CHEMBL3526652 | |
| 0.009 | 0.123 | 0.055 | Complement C3a chemotactic receptor antagonist | 0.055 0.024 CHEMBL3527502 | CHEMBL3527502 | |
| 0.018 | 0.138 | 0.039 | Cholecystokinin B agonist | 0.039 0.024 CHEMBL3527502 | CHEMBL3527502 | |
| 0.117 | 0.241 | 0.528 | Hypoglycemic | 0.528 0.013 CHEMBL3527501 | CHEMBL3527501 | |
| 0.039 | 0.167 | 0.073 | Somatostatin 1 agonist | 0.073 0.06 CHEMBL3527502 | CHEMBL3527502 | |
| 0.018 | 0.148 | 0.052 | Collagenase inhibitor | 0.052 0.028 CHEMBL3527502 | CHEMBL3527502 | |
| 0.133 | 0.265 | 0.327 | Angiogenesis inhibitor | 0.327 0.08 CHEMBL3527501 | CHEMBL3527501 | |
| 0.055 | 0.193 | 0.159 | Proteasome inhibitor | 0.159 0.042 CHEMBL3527502 | CHEMBL3527502 | |
| 0.027 | 0.166 | 0.073 | Glucose-6-phosphate translocase inhibitor | 0.073 0.014 CHEMBL3527501 | CHEMBL3527501 | |
| 0.046 | 0.187 | 0.12 | Cell adhesion molecule inhibitor | 0.12 0.024 CHEMBL3527501 | CHEMBL3527501 | |
| 0.056 | 0.202 | 0.106 | Bone formation stimulant | 0.106 0.1 CHEMBL3527502 | CHEMBL3527502 | |
| 0.013 | 0.163 | 0.042 | Carbonic anhydrase I stimulant | 0.042 0.022 CHEMBL3527502 | CHEMBL3527502 | |
| 0.081 | 0.232 | 0.139 | DNA repair enzyme inhibitor | 0.139 0.043 CHEMBL3527501 | CHEMBL3527501 | |
| 0.007 | 0.158 | 0.05 | Purinergic P2Y12 antagonist | 0.05 0.007 CHEMBL3526652 | CHEMBL3526652 | |
| 0.013 | 0.167 | 0.067 | Glycine transporter 2 inhibitor | 0.067 0.022 CHEMBL3527502 | CHEMBL3527502 | |
| 0.015 | 0.17 | 0.047 | Aldose reductase inhibitor | 0.047 0.041 CHEMBL3527501 | CHEMBL3527501 | |
| 0.002 | 0.166 | 0.064 | Purinergic P2 agonist | 0.064 0.002 CHEMBL3526652 | CHEMBL3526652 | |
| 0.002 | 0.166 | 0.064 | Purinergic receptor agonist | 0.064 0.002 CHEMBL3526652 | CHEMBL3526652 | |
| 0.021 | 0.188 | 0.205 | Purinergic P2 antagonist | 0.205 0.007 CHEMBL3526652 | CHEMBL3526652 | |
| 0.161 | 0.336 | 0.606 | Apoptosis agonist | 0.606 0.048 CHEMBL3527501 | CHEMBL3527501 | |
| 0.037 | 0.216 | 0.06 | Lipocortins synthesis agonist | 0.06 0.035 CHEMBL3527501 | CHEMBL3527501 | |
| 0.076 | 0.256 | 0.425 | Nitric oxide antagonist | 0.425 0.023 CHEMBL3527501 | CHEMBL3527501 | |
| 0.002 | 0.182 | 0.055 | Purinergic P2Y agonist | 0.055 0.002 CHEMBL3526652 | CHEMBL3526652 | |
| 0.047 | 0.228 | 0.179 | DNA directed RNA polymerase inhibitor | 0.179 0.017 CHEMBL3526652 | CHEMBL3526652 | |
| 0.006 | 0.193 | 0.061 | Inosine monophosphate dehydrogenase 1 inhibitor | 0.061 0.004 CHEMBL3526652 | CHEMBL3526652 | |
| 0.026 | 0.217 | 0.054 | Carbonic anhydrase II stimulant | 0.054 0.032 CHEMBL3527502 | CHEMBL3527502 | |
| 0.038 | 0.231 | 0.074 | Chymotrypsin inhibitor | 0.074 0.062 CHEMBL3527502 | CHEMBL3527502 | |
| 0.038 | 0.232 | 0.133 | Topoisomerase II inhibitor | 0.133 0.058 CHEMBL3527501 | CHEMBL3527501 | |
| 0.005 | 0.2 | 0.084 | Purinergic P2Y1 antagonist | 0.084 0.003 CHEMBL3526652 | CHEMBL3526652 | |
| 0.005 | 0.207 | 0.049 | Adenosine A1 receptor agonist | 0.049 0.006 CHEMBL3526652 | CHEMBL3526652 | |
| 0.015 | 0.221 | 0.159 | Antineoplastic antibiotic | 0.159 0.029 CHEMBL3527501 | CHEMBL3527501 | |
| 0.045 | 0.254 | 0.107 | Multidrug resistance-associated protein 1 inhibitor | 0.107 0.067 CHEMBL3527501 | CHEMBL3527501 | |
| 0.012 | 0.222 | 0.043 | Endothelin-converting enzyme inhibitor | 0.043 0.036 CHEMBL3527502 | CHEMBL3527502 | |
| 0 | 0.214 | 0.006 | Purinergic P2Y4 agonist | 0.006 0.002 CHEMBL3526652 | CHEMBL3526652 | |
| 0.013 | 0.227 | 0.064 | Aminopeptidase N inhibitor | 0.064 0.023 CHEMBL3527502 | CHEMBL3527502 | |
| 0.019 | 0.235 | 0.093 | Nitric oxide donor | 0.066 0.039 CHEMBL3527501 0.093 0.012 CHEMBL3527502 | CHEMBL3527502 | |
| 0.016 | 0.234 | 0.055 | Microtubule stabilization | 0.055 0.022 CHEMBL3527501 | CHEMBL3527501 | |
| 0.042 | 0.264 | 0.085 | Thioredoxin inhibitor | 0.085 0.071 CHEMBL3527501 | CHEMBL3527501 | |
| 0.019 | 0.242 | 0.084 | Aminopeptidase microsomal inhibitor | 0.084 0.023 CHEMBL3527502 | CHEMBL3527502 | |
| 0.02 | 0.248 | 0.043 | Cathepsin F inhibitor | 0.043 0.026 CHEMBL3527502 | CHEMBL3527502 | |
| 0.033 | 0.266 | 0.101 | ATPase (Vacuolar H+) inhibitor | 0.101 0.038 CHEMBL3527501 | CHEMBL3527501 | |
| 0.033 | 0.281 | 0.089 | Protein kinase C mu inhibitor | 0.089 0.069 CHEMBL3527501 | CHEMBL3527501 | |
| 0.066 | 0.314 | 0.136 | Interleukin 6 antagonist | 0.136 0.113 CHEMBL3527501 | CHEMBL3527501 | |
| 0.015 | 0.279 | 0.093 | Protein 50S ribosomal subunit inhibitor | 0.093 0.015 CHEMBL3527501 | CHEMBL3527501 | |
| 0.032 | 0.315 | 0.116 | Chelator | 0.116 0.058 CHEMBL3527502 | CHEMBL3527502 | |
| 0.057 | 0.342 | 0.148 | P-glycoprotein inhibitor | 0.148 0.119 CHEMBL3527501 | CHEMBL3527501 | |
| 0.1 | 0.386 | 0.232 | Toll-Like receptor agonist | 0.232 0.166 CHEMBL3527502 | CHEMBL3527502 | |
| 0.054 | 0.348 | 0.324 | Platelet antagonist | 0.249 0.073 CHEMBL3526652 0.246 0.074 CHEMBL3527501 0.324 0.045 CHEMBL3527502 | CHEMBL3527502 | |
| 0.018 | 0.317 | 0.078 | Protein kinase A inhibitor | 0.078 0.062 CHEMBL3527501 | CHEMBL3527501 | |
| 0.012 | 0.316 | 0.081 | Glucagon-like peptide 1 agonist | 0.081 0.034 CHEMBL3527502 | CHEMBL3527502 | |
| 0.062 | 0.373 | 0.278 | Growth hormone agonist | 0.278 0.037 CHEMBL3527502 | CHEMBL3527502 | |
| 0.023 | 0.344 | 0.116 | Protease inhibitor | 0.116 0.051 CHEMBL3527502 | CHEMBL3527502 | |
| 0.017 | 0.344 | 0.086 | Analgesic, opioid | 0.086 0.041 CHEMBL3527502 | CHEMBL3527502 | |
| 0.014 | 0.342 | 0.067 | Antibiotic Aminoglycoside-like | 0.067 0.007 CHEMBL3527501 | CHEMBL3527501 | |
| 0.005 | 0.333 | 0.045 | Kinesin antagonist | 0.045 0.019 CHEMBL3527502 | CHEMBL3527502 | |
| 0.005 | 0.333 | 0.045 | Kinesin-like protein 1 inhibitor | 0.045 0.019 CHEMBL3527502 | CHEMBL3527502 | |
| 0.005 | 0.345 | 0.02 | Adenosine A3 receptor agonist | 0.02 0.009 CHEMBL3526652 | CHEMBL3526652 | |
| 0.017 | 0.367 | 0.091 | Topoisomerase II alpha inhibitor | 0.091 0.045 CHEMBL3527501 | CHEMBL3527501 | |
| 0.005 | 0.368 | 0.019 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.019 0.007 CHEMBL3526652 | CHEMBL3526652 | |
| 0.021 | 0.388 | 0.055 | Antiviral (Hepatitis D) | 0.055 0.029 CHEMBL3526652 | CHEMBL3526652 | |
| 0.044 | 0.413 | 0.435 | Platelet adhesion inhibitor | 0.435 0.009 CHEMBL3527501 | CHEMBL3527501 | |
| 0.012 | 0.387 | 0.041 | Toll-Like receptor 4 agonist | 0.041 0.005 CHEMBL3526652 0.031 0.01 CHEMBL3527501 | CHEMBL3526652 | |
| 0.047 | 0.427 | 0.434 | Tumour necrosis factor alpha release inhibitor | 0.193 0.116 CHEMBL3526652 0.434 0.021 CHEMBL3527501 | CHEMBL3527501 | |
| 0.01 | 0.4 | 0.046 | Erythropoietin receptor agonist | 0.046 0.024 CHEMBL3527502 | CHEMBL3527502 | |
| 0.005 | 0.402 | 0.017 | Adenosine A2b receptor agonist | 0.017 0.007 CHEMBL3526652 | CHEMBL3526652 | |
| 0.023 | 0.435 | 0.335 | Neurotrophic factor | 0.129 0.082 CHEMBL3526652 0.335 0.006 CHEMBL3527502 | CHEMBL3527502 | |
| 0.031 | 0.444 | 0.16 | Toll-Like receptor 4 antagonist | 0.151 0.02 CHEMBL3526652 0.16 0.016 CHEMBL3527501 | CHEMBL3527501 | |
| 0.068 | 0.486 | 0.636 | Immunomodulator | 0.636 0.009 CHEMBL3526652 0.428 0.037 CHEMBL3527501 0.3 0.082 CHEMBL3527502 | CHEMBL3526652 | |
| 0.015 | 0.438 | 0.07 | Sirtuin 1 inhibitor | 0.07 0.045 CHEMBL3527502 | CHEMBL3527502 | |
| 0.005 | 0.443 | 0.027 | Bradykinin B2 receptor agonist | 0.027 0.022 CHEMBL3527502 | CHEMBL3527502 | |
| 0.028 | 0.481 | 0.099 | Nav1.4 sodium channel blocker | 0.099 0.078 CHEMBL3527502 | CHEMBL3527502 | |
| 0.014 | 0.479 | 0.183 | Topoisomerase I inhibitor | 0.183 0.031 CHEMBL3527501 | CHEMBL3527501 | |
| 0.013 | 0.481 | 0.052 | Cathepsin B inhibitor | 0.052 0.046 CHEMBL3527502 | CHEMBL3527502 | |
| 0.012 | 0.499 | 0.039 | Neurokinin 2 agonist | 0.039 0.033 CHEMBL3527502 | CHEMBL3527502 | |
| 0.022 | 0.511 | 0.196 | Anticoagulant | 0.182 0.06 CHEMBL3527501 0.196 0.054 CHEMBL3527502 | CHEMBL3527502 | |
| 0.005 | 0.503 | 0.037 | Protein 30S ribosomal subunit inhibitor | 0.037 0.011 CHEMBL3527501 | CHEMBL3527501 | |
| 0.03 | 0.542 | 0.342 | Vasodilator | 0.299 0.048 CHEMBL3526652 0.342 0.035 CHEMBL3527501 0.239 0.076 CHEMBL3527502 | CHEMBL3527501 | |
| 0.017 | 0.544 | 0.09 | Factor XII inhibitor | 0.09 0.049 CHEMBL3527502 | CHEMBL3527502 | |
| 0.03 | 0.564 | 0.156 | Histone deacetylase SIRT1 inhibitor | 0.156 0.057 CHEMBL3527502 | CHEMBL3527502 | |
| 0.052 | 0.645 | 0.292 | Caspase 3 stimulant | 0.292 0.083 CHEMBL3527501 | CHEMBL3527501 | |
| 0.012 | 0.682 | 0.054 | Bombesin 1 receptor agonist | 0.054 0.049 CHEMBL3527502 | CHEMBL3527502 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |